International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 1
January-February 2026
Indexing Partners
Development of a Deterministic Web Tool for Evaluation of Fixed-Dose Combinations
| Author(s) | Mr. Omkar Ramesh Kahane, Mr. Amit Avinash Deshmukh, Ms. Vanshita Kishor Patil, Mr. Rohak Sandip Mahajan |
|---|---|
| Country | India |
| Abstract | Fixed-dose combinations (FDCs) are widely utilised pharmaceutical products combining two or more active ingredients in a fixed ratio, developed with the aim of improving therapeutic convenience and patient adherence. However, deviations from established pharmacological principles during FDC development have resulted in formulations that lack clear evidence of benefit or introduce unnecessary safety risks. In India and other low- and middle-income countries, the prevalence of non-recommended and irrational FDCs remains substantial despite large-scale regulatory bans, reflecting gaps between policy interventions and enforcement effectiveness. Current identification of irrational FDCs is predominantly retrospective, occurring through post-marketing regulatory reviews and policy-based restrictions rather than through prospective screening at the formulation stage. This work operationalises a previously described, deterministic, rule-based pharmacological framework into an interactive web-based tool—the Predictive FDC Risk Analyzer v3.1—that provides transparent, narrative-based appraisal of mechanistic compatibility, pharmacokinetic alignment and safety overlap for two-drug combinations. The tool executes entirely within the user's browser, does not access patient-level data and explicitly restricts its intended use to educational and conceptual screening contexts without clinical validation or regulatory authority. Illustrative case examples demonstrate that the tool generates consistent, qualitative verdicts for rational, high-risk and policy-restricted combinations, reflecting the underlying rule-based logic in a transparent manner. The Analyzer serves as a structured, reproducible framework for teaching and early-stage reasoning around fixed-dose combination pharmacology, but does not provide empirical risk prediction and must not be used for clinical decision-making or regulatory submission. |
| Keywords | Fixed‑dose combinations; Rational pharmacotherapy; Drug combinations; Pharmacological screening; Rule‑based systems; Pharmaceutical education. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 1, January-February 2026 |
| Published On | 2026-02-04 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i01.67906 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.